Homechevron_rightAll Peptideschevron_rightCerebrolysin

verified_user

Safety data sheet

Standardized safety protocols and material specifications for professional use.

analytics

Certificate of Analysis

Purity verified via High-Performance Liquid Chromatography (HPLC) for #myo-cerebrolysin-60mg

Official Product Data Sheet

Cerebrolysin (60mg)

High >98% Purity

Vial Contents

60 mg Cerebrolysin (lyophilized porcine brain hydrolysate)

Includes

3 ml bacteriostatic water for reconstitution

Form

Lyophilized powder — porcine brain-derived neuropeptide complex

Purity

≥99%, high-purity, third-party tested (COA available)

Sequence

Swine brain hydrolysate: low-molecular-weight neuropeptides (<10 kDa) and free amino acids

Molecular Formula

See chemical properties

Molecular Mass

Variable (peptide mixture, components <10 kDa)

CAS No.

12656-61-0

Solubility

Reconstitutes with bacteriostatic water to 20 mg/mL (3 ml per vial)

Storage

Lyophilized at ≤25 °C in dry, dark conditions; reconstituted refrigerated at 2–8 °C for up to 7 days — do not freeze after reconstitution

Authorized Resellers

Available through our trusted partners

verifiedVerified

123peptide.com

Netherlands · Europe

local_shipping2-3 Business Days

Buy from Partneropen_in_new

verifiedVerified

Depeptidenwinkel.com

Netherlands · Europe

local_shipping2-3 Business Days

Buy from Partneropen_in_new

View all authorized resellersshopping_cart

swipe_rightSwipe to see all tabs

Scientific Background

Cerebrolysin is a porcine (swine) brain-derived hydrolysate containing low-molecular-weight neuropeptides and free amino acids that cross the blood-brain barrier to mimic endogenous neurotrophic factors such as NGF (nerve growth factor) and BDNF (brain-derived neurotrophic factor).

It supports neuronal survival, synaptic plasticity, and neuroprotection in preclinical and clinical models of stroke, traumatic brain injury, and neurodegeneration. Its multimodal mechanism includes modulation of neuroinflammatory pathways and promotion of functional recovery.

Clinical trials and meta-analyses indicate improvements in cognitive function, global clinical impression in Alzheimer's and vascular dementia, and neurological recovery in acute ischemic stroke.